Workflow
SPRYNG with OsteoCushion Technology
icon
Search documents
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED
Globenewswire· 2025-09-02 12:00
Core Points - PetVivo Animal Health, Inc. has entered into a distribution agreement with Nupsala Limited to market its veterinary medical device, Spryng with OsteoCushion technology, in the United Kingdom [1][2] - The distribution activities by Nupsala commenced on September 1, 2025, aiming to enhance the accessibility of Spryng to veterinarians and animal owners [1][2] - Spryng with OsteoCushion technology is designed to manage joint pain in animals by promoting proper joint mechanics and integrating with subsynovial tissue [3][4] Company Overview - PetVivo Holdings, Inc. focuses on the commercialization of innovative medical devices and therapeutics for companion animals, leveraging human therapies for efficient treatment [5] - The company has a robust pipeline of products, including Spryng and PrecisePRP, and holds a portfolio of twenty-one patents protecting its biomaterials and methods [6] Partner Overview - Nupsala Limited specializes in musculoskeletal health and regenerative medicine for companion animals and horses, operating as both a veterinary wholesaler and referral provider [8][9] - Nupsala aims to improve animal mobility and deliver innovative solutions through clinical trials, diagnostics, and educational initiatives [9]
PetVivo Holdings Inc. to Trade on OTCQX Best Market
Globenewswire· 2025-07-30 11:30
Core Insights - PetVivo Holdings, Inc. has successfully upgraded to trade on the OTCQX Best Market, enhancing its visibility and accessibility for investors [1][3][6] - The company specializes in innovative biomedical devices and therapeutics for horses and companion animals, with key products including SPRYNG with OsteoCushion Technology and PrecisePRP [1][4][5] Company Overview - PetVivo Holdings, Inc. focuses on the manufacturing, commercialization, and licensing of medical devices and therapeutics for equine and companion animals, leveraging human therapies for efficient treatment [7][8] - The company has a robust pipeline of products protected by twelve patents and six trade secrets, indicating a strong intellectual property position [8] Product Details - SPRYNG with OsteoCushion Technology is an injectable veterinary medical device that aids in managing joint pain by restoring proper joint mechanics [4] - PrecisePRP is a first-in-class, off-the-shelf platelet-rich plasma product designed for veterinarians, providing a consistent dose of 4 billion platelets per vial [5]